Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
Abstract:
The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
Public/Granted literature
Information query
Patent Agency Ranking
0/0